The 10 Best Marijuana Stocks to Buy in 2019

Dec 11, 2018, 12:07 pm EST

The 10 Best Marijuana Stocks to Buy in 2019

Although marijuana stocks have suffered sharp losses recently, the overall industry is only growing in prominence.

By Josh Enomoto, InvestorPlace Contributor

Diego Pellicer Worldwide (DPWW)

We’ve arrived at the end of our journey regarding marijuana stocks to buy in 2019. In keeping with my loose tradition, I like to throw in an extremely speculative name. And don’t roll your eyes at me: you know you want to know!

The following idea comes from an InvestorPlace reader named Anthony. He asked my opinion regarding Diego Pellicer Worldwide (OTCMKTS:DPWW). My answer to him is the same one I’m giving to you, which is that DPWW stock is extremely risky. Aside from its distressingly low trading volume and market capitalization, Diego Pellicer lacks financial strength to convincingly pull off its licensing and royalties business model.

However, I’m intrigued with its premium branding business. Not that I would know, but Diego Pellicer specializes in high-class cannabis products. As companies like Origin House and Medmen have proven, cannabis users eschew quantity for quality. That could lead to a surprising turnaround for DPWW stock.

Or you can lose every cent that you put in.

Read more…

Diego Pellicer Annual Sales and National Cannabis Accolades

Diego Pellicer Annual Sales and National Cannabis Accolades

By ME Staff -December 11, 2018

This year’s Cannabis market has been good for Diego Pellicer Worldwide Inc (OTCMKTS:DPWW). The company recently announced a 150% increase in annual sales for the fiscal year ending December 01 2018.

Projected Cannabis Market

Apparently the cannabis wing for the Colarado company, is having a great run in the growing US cannabis market even before the market fully opens up nationally. Statistics by the New Frontier Data valued the US cannabis market at $8.3 billion in 2017. However, as the nation gears to decriminalizing cannabis use, the marketed is estimated to triple at a compounded annual rate of 14.7% to about $25 billion in 2025.

Companies are in a rush to partake in the lucrative sector setting up multiple dispensaries and retail outlets.

Read more…